Wegovy and Clearpay: understanding your payment options

Why Wegovy and Clearpay don't mix the way you might expect

The search for Wegovy on Clearpay is understandable. Monthly treatment costs are real, and spreading payments is a sensible way to manage any significant outgoing. The difficulty is that Clearpay, like other buy-now-pay-later services, is designed for off-the-shelf retail purchases. A medicine requiring a prescription sits in a different legal category entirely.

Under the Human Medicines Regulations 2012, Wegovy cannot be supplied without a valid prescription from a registered prescriber. That prescription must follow a genuine clinical assessment: checking your medical history, your current medicines, your BMI, and any conditions that might affect whether treatment is appropriate for you. Clearpay's checkout sits upstream of all that, it handles payment at the point of sale, not the point of prescribing. Genuine UK pharmacies therefore cannot route Wegovy through a standard Clearpay integration, because the compliance steps happen after a patient order is placed, not before it.

If you see a seller advertising Wegovy on Clearpay with no clinical assessment required, that is a significant red flag. The MHRA's Yellow Card reporting service accepts reports of suspect sellers, and the regulator has repeatedly warned the public about counterfeit and illegally supplied weight-loss pens circulating through online and social media channels. A small saving is not worth the risk of receiving something that has never been through a licensed supply chain.

What legitimate flexible payment options do exist for Wegovy UK?

The fact that Clearpay isn't the right route doesn't mean spreading the cost is impossible. Some regulated private pharmacies and clinics have introduced their own payment arrangements, instalment plans managed within the pharmacy's own systems, rather than routed through consumer credit apps. These vary considerably between providers, and it is worth reading the small print carefully: some require a subscription commitment, auto-renew without a fresh clinical review, or charge separate consultation and delivery fees that make the headline instalment misleading.

At nume, we don't tie treatment to subscriptions or auto-renewals. Our guide to private Wegovy payment explains how our pricing is structured, and every repeat order goes through a fresh clinical review rather than rolling forward automatically. If you want to understand the payment landscape more broadly before committing, our self-pay Wegovy page breaks down what a self-funded course of treatment typically involves month to month.

It is also worth knowing that Wegovy is available on the NHS for people who meet NICE's criteria (TA875), though waiting times through specialist weight management services are often long. NICE's recommendation for semaglutide sets out the eligibility thresholds if you want to explore that route first.

How much does Wegovy actually cost privately, and what should that price cover?

Private Wegovy pricing in the UK varies by dose and provider. Eli Lilly's September 2025 list-price increase for Mounjaro prompted wider attention to GLP-1 medicine costs, and semaglutide pricing has also shifted across providers over that period, so if you're weighing up your options it's worth reading our page on how much Wegovy is to buy privately, as typical costs run roughly in the region of £149–£375 per month depending on dose, though these figures change, so it pays to check the current position directly with any pharmacy you're considering.

What matters just as much as the headline figure is what that price includes. Our Wegovy pricing breakdown covers this in detail, but as a quick benchmark: a legitimate all-in price should include the consultation, the prescription, the medicine itself and delivery. Platforms that quote a low medicine price and then add separate consultation or delivery charges at checkout can end up costing more in practice. You can also compare the broader cost of Wegovy across different approaches to treatment if you want a fuller picture before deciding.

For a detailed look at phased or monthly payment approaches some providers offer, the pay monthly Wegovy page covers the options and what to watch for.

Making a sound decision about Wegovy payment

The central question isn't which payment platform to use, it's whether you can access a clinically sound, genuinely supplied course of treatment at a price that's sustainable for the months it takes to see results. Wegovy is not a short-term purchase; most people take it for at least a year alongside lifestyle changes, and the NHS's patient guidance on semaglutide is worth reading before you start.

That longer timeframe is one reason the payment structure matters. A cheap first month that locks you into a subscription, or a low-price pen from an unverified seller, can create problems (clinically and financially) that outweigh the initial saving. Think of it like the weekly Wegovy pen sitting in the fridge door: you need to know the medicine inside is genuine, not just that the box arrived quickly.

If you're ready to find out whether Wegovy is clinically appropriate for you, the best starting point is a proper consultation with a registered prescriber. At nume, that consultation is free, reviewed the same day by a GPhC-registered Independent Prescriber, and includes ID and weight verification before anything is dispensed. You can learn more about our clinical team on the clinical team page or explore the full range of weight-loss treatments we offer. When you're ready, start your free consultation and get a clear answer on whether you're eligible.